Back to search

Article

Mutant RIT1 cooperates with YAP to drive an EMT-like lung cancer state

2024-11-12

Abstract excerpt

<h4>ABSTRACT</h4> The discovery of oncogene addiction in cancer has led to the development of over a dozen FDA-approved biomarker-driven therapies in lung adenocarcinoma. Somatic mutations of the “Ras-like in all tissues” (RIT1) gene are non-canonical driver events in lung cancer, occurring in ∼2% of lung adenocarcinomas in a mutually exclusive fashion with KRAS and EGFR mutations. Patients with RIT1 -mutant l...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
261219e9-e3d3-5cb2-b6fe-13e7b96b1527
DOI
10.1101/2024.11.11.623044
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Mutant RIT1 cooperates with YAP to drive an EMT-like lung cancer stateDOI 10.1101/2024.11.11.623044
Select a neighboring publication to make it the new centre.